TERAPIE VENETOCLAX + AZACYTIDIN  U PACIENTŮ S AKUTNÍ MYELOIDNÍ  LEUKEMIÍ (AML) VEDE JEN ZŘÍDKA  K ELIMINACI LEUKEMICKÉHO KLONU,  I KDYŽ JE PŘÍTOMNA MORFOLOGICKÁ  REMISE

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	VENETOCLAX + AZACYTIDINE THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) RARELY RESULTS IN THE ELIMINATION OF THE LEUKAEMIC CLONE, EVEN WHEN MORPHOLOGICAL REMISSION IS PRESENT
Authors	MAYER Jiří JEŽÍŠKOVÁ Ivana SEMERÁD Lukáš KLEMEŠOVÁ Iveta VAŠÍKOVÁ Alžběta FOLTA A. DRNCOVÁ Marie PODSTAVKOVÁ N. KABUT Tomáš MRKVOVÁ Zuzana VOLDŘICH Jakub DIATKOVÁ Jana HOLEČKOVÁ Viktória KVETKOVÁ Anežka PROCHÁZKOVÁ Jiřina BORSKÝ Marek WEINBERGEROVÁ Barbora
Year of publication	2024
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	VENETOCLAX + AZACYTIDINE THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) RARELY RESULTS IN THE ELIMINATION OF THE LEUKAEMIC CLONE, EVEN WHEN MORPHOLOGICAL REMISSION IS PRESENT - conference abstract.
Related projects:	National institute for cancer research